A federal judge granted preliminary approval on April 22, 2026, to a $59.5 million class action settlement resolving claims that Flo Health, Google, and Flurry improperly shared women's menstrual and reproductive health data with third parties without adequate user consent [1]. The settlement covers users of Flo Health's period and fertility tracking application who allege their sensitive health information was transmitted to advertising and analytics platforms without meaningful disclosure.
The claims center on the alleged sharing of data, including information about menstrual cycles, pregnancy status, and related health inputs, with third-party recipients such as Google and Flurry, which operates as a Yahoo analytics service. Plaintiffs argued that this data sharing violated user expectations and applicable federal and state privacy law. Flo Health, incorporated in the United Kingdom and operating one of the most widely downloaded women's health applications in the United States, had previously reached a separate settlement with the Federal Trade Commission in 2021 over related allegations that it shared health data with Facebook and Google for advertising purposes after representing to users that such data would remain private [1]. That FTC resolution required Flo Health to obtain user consent before sharing health data and to instruct third parties to delete improperly obtained information.
The present litigation aggregates claims from a putative class of app users and names Google and Flurry as co-defendants on the theory that each entity received and processed the disputed data. Preliminary approval signals that the court has found the settlement within the range of reasonableness for purposes of notifying class members and proceeding toward a final fairness hearing, though it does not constitute a final adjudication of the merits or the settlement's adequacy [1].
The next step is formal class notice, after which class members will have an opportunity to object or opt out before a final approval hearing. The size of the settlement, and the involvement of a major technology platform alongside a health application developer, positions this case as a reference point for litigation and regulatory scrutiny involving sensitive health data collected by consumer apps. Congressional interest in federal health data privacy legislation has increased following the Supreme Court's 2022 decision in Dobbs v. Jackson Women's Health Organization, which elevated concern over the legal exposure that reproductive health data may create for users in states with abortion restrictions.